CI Investments Inc. cut its position in Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) by 56.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,382 shares of the technology company’s stock after selling 90,583 shares during the period. CI Investments Inc.’s holdings in Celestica were worth $19,825,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. NewGen Equity Long Short Fund bought a new stake in shares of Celestica during the second quarter valued at approximately $14,050,000. Northwestern Mutual Wealth Management Co. raised its holdings in Celestica by 7,646.2% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,007 shares of the technology company’s stock worth $157,000 after buying an additional 994 shares during the last quarter. First Trust Advisors LP grew its holdings in shares of Celestica by 30.0% during the second quarter. First Trust Advisors LP now owns 78,061 shares of the technology company’s stock valued at $12,197,000 after buying an additional 18,025 shares during the last quarter. NewEdge Advisors LLC lifted its position in Celestica by 385.8% in the 2nd quarter. NewEdge Advisors LLC now owns 2,803 shares of the technology company’s stock valued at $438,000 after acquiring an additional 2,226 shares in the last quarter. Finally, HUB Investment Partners LLC raised its stake in shares of Celestica by 11.0% in the second quarter. HUB Investment Partners LLC now owns 3,181 shares of the technology company’s stock worth $497,000 after purchasing an additional 315 shares during the last quarter. 67.38% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of Celestica stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the completion of the sale, the chief financial officer directly owned 82,444 shares in the company, valued at $32,948,744.60. The trade was a 17.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Michael Max Wilson sold 4,168 shares of Celestica stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total value of $1,389,236.08. Following the sale, the director directly owned 24,718 shares of the company’s stock, valued at approximately $8,238,756.58. This trade represents a 14.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 161,168 shares of company stock worth $63,190,485. Insiders own 1.10% of the company’s stock.
Celestica Trading Down 1.2%
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last announced its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.08. The company had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Celestica had a return on equity of 36.91% and a net margin of 6.95%.The firm’s quarterly revenue was up 52.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.20 earnings per share. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, analysts anticipate that Celestica, Inc. will post 9.57 earnings per share for the current year.
Celestica News Roundup
Here are the key news stories impacting Celestica this week:
- Positive Sentiment: Analyst commentary remains constructive ahead of earnings, citing strong demand in AI infrastructure, cloud, and healthcare, along with rising estimates and the potential for another earnings beat. Celestica to Release Q2 Earnings: How to Approach the Stock Now?
- Positive Sentiment: Some bullish research says Celestica has improved long-term revenue visibility, with AI infrastructure tailwinds and resolved component shortages supporting guidance and future growth. Celestica: The Market Just Started To Agree, And Q2 Isn’t Posed Yet
- Neutral Sentiment: Recent articles focus on valuation, with some saying the stock may still screen as inexpensive on earnings expectations while others argue it has already run far enough that upside is less certain. Celestica (TSX:CLS) Stock Looks Above Fair Value Despite Its Huge Run
- Neutral Sentiment: Market watchers are also debating whether the upcoming quarter can support the stock’s prior surge, with one preview framing Q2 as a key test for the AI hardware trade. Celestica Q2 Preview: The 1.6T Supercycle Meets The Overbuild Dilemma
- Negative Sentiment: The stock has been under pressure recently, with traders noting a deeper pullback than the broader market and a move into bear-market territory after a sharp run-up. Celestica (CLS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Negative Sentiment: Another note said Celestica’s shares have dropped sharply from this year’s highs, reflecting concern that a lot of the AI growth story may already be priced in. Celestica stock tumbles ahead of earnings: rebound or more pain?
Analyst Ratings Changes
Several equities analysts have weighed in on the company. UBS Group raised their price objective on Celestica from $355.00 to $400.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Weiss Ratings lowered shares of Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, July 16th. Stifel Nicolaus set a $445.00 target price on Celestica in a report on Tuesday, April 28th. Bank of America increased their price target on shares of Celestica from $400.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Finally, Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating and issued a $480.00 price target on shares of Celestica in a report on Wednesday, April 29th. Two analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $427.42.
View Our Latest Research Report on Celestica
About Celestica
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
See Also
- Five stocks we like better than Celestica
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
